Development of vaccines for Chagas disease (CRUZIVAX): stakeholders¿ preferences and potential impacts on healthcare Francesco Ramponi; Céline Aerts; Paula Sartor; María Jesús Pinazo; Héctor Freilij; Carlos A. Guzmán; Emilio Malchiodi; Elisa Sicuri;